ToolGen Incorporated
199800.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$300.89B
Close$
$-920.19
103% downside
Current Fair Value
103% downsideOvervalued by 103% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $300.89 Billion |
|---|---|
| Enterprise Value | $292.43 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4099.41 |
| Beta | 1.24 |
| Outstanding Shares | 9,143,692 |
Return
| Return on Equity | -84.13% |
|---|---|
| Return on Assets | -76.24% |
| Return on Invested Capital | -80.49% |
Valuation & Multiples
| P/E Ratio | -7.65 |
|---|---|
| PEG | -14.06 |
| Price to Sales | 144.74 |
| Price to Book Ratio | 5.95 |
| Enterprise Value to Revenue | 152.89 |
| Enterprise Value to EBIT | -7.56 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ToolGen Incorporated
84 employees
CEO: Young Kim ToolGen Incorporated is a biotechnology enterprise based in South Korea, primarily focused on pioneering advancements in genome editing technology. The company's main endeavor involves engineering CRISPR-Cas9 genetic modification tools s...